UF researchers to study gut bacteria and T1D
A group of UF researchers will use a new $3.3 million grant to evaluate safety, tolerability, and general response to the probiotic Lactobacillus johnsonii N6.2 in people with T1D. The scientists aim to determine if the probiotic has a positive impact on gastrointestinal health and general wellness for individuals with T1D.